Bioengineering of bacteria for cancer immunotherapy

Here, we provide a brief overview of the approaches and strategies underlying bacteria-based cancer immunotherapy (BCiT). We also describe and summarize research in the field of synthetic biology, which aims to regulate bacterial growth and gene expression for immunotherapeutic use. Finally, we discuss the current clinical status and limitations of BCiT.

Automated summary

This article provides a brief overview of the approaches and strategies used in bacteria-based cancer immunotherapy (BCiT). It also discusses research in the field of synthetic biology, which aims to regulate bacterial growth and gene expression for immunotherapeutic purposes. Finally, the current clinical status and limitations of BCiT are examined.